Search

Agilent Technologies Inc

Open

SectorHealthcare

133.53 0.51

Overview

Share price change

24h

Current

Min

124.35

Max

134.58

Key metrics

By Trading Economics

Income

34M

339M

Sales

37M

1.8B

P/E

Sector Avg

26.368

62.58

EPS

1.49

Dividend yield

0.77

Profit margin

18.474

Employees

18,000

EBITDA

44M

500M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+16.76% upside

Dividends

By Acuity

Dividend yield

Sector Avg

0.77%

2.19%

Next Earnings

26 Aug 2026

Next Dividend date

22 Jul 2026

Next Ex Dividend date

29 Sept 2026

Market Stats

By TradingEconomics

Market Cap

4.3B

37B

Previous open

133.02

Previous close

133.53

News Sentiment

By Acuity

93%

7%

321 / 340 Healthcare

Agilent Technologies Inc Chart

Past performance is not a reliable indicator of future results.

Related News

21 Jul 2026, 20:02 UTC

News

Agilent Technologies has received FDA approval for its PD-L1 IHC 28-8 assay, boosting shares as analysts express positive sentiment on its future prospects.

20 Jul 2026, 19:22 UTC

News

Agilent Technologies Inc. shares are lower amid broader market declines and rising Treasury yields, despite a "Moderate Buy" consensus from analysts.

Peer Comparison

Price change

Agilent Technologies Inc Forecast

Price Target

By TipRanks

16.76% upside

12 Months Forecast

Average 155.13 USD  16.76%

High 180 USD

Low 135 USD

Based on 16 Wall Street analysts offering 12 month price targets forAgilent Technologies Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

16 ratings

13

Buy

3

Hold

0

Sell

Sentiment

By Acuity

321 / 340 Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
help-icon Live chat